IBRX
IBRX
NASDAQ · Biotechnology

Immunitybio Inc

Mid-Cap Stocks Stocks Under $10 Biotech Stocks Healthcare Stocks
$7.60
+0.30 (+4.11%)
As of Apr 14, 9:50 PM ET ·
Analyst Consensus
Strong Buy
11
Analysts
Moderate
Coverage
Buy 10 91%
Hold 1 9%
Sell 0 0%
Price Target
Analyst Price Target +1,331.4% upside
Low Target $71.54
Average Target $108.79
High Target $142.95
Current Price $7.60
Current
$7.60
Target
$108.79
$71.54 $108.79 avg $142.95
Scenario Analysis
Bear Case
$71.54
841.3%
Low target
Base Case
$108.79
+1,331.4%
Avg target
Bull Case
$142.95
+1,780.9%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$12.43
-38.9% from high
52-Week Low
$1.83
+315.3% from low
50-Day SMA
$4.22
+80.1% vs SMA
200-Day SMA
$2.95
+157.6% vs SMA
RSI (14)
70.9
Overbought
Target vs 52W High
$108.79
+775.2% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Buy 39 72% $257.58 +22.5%
AMGN
Amgen Inc
 Hold 43 49% $190.87 -45.6%
GILD
Gilead Sciences Inc
 Strong Buy 39 79% $362.68 +158.2%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 -1.3%
REGN
Regeneron Pharmaceuticals
 Strong Buy 38 79% $76.80 -89.8%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 75% $102.31 -69.9%
INSM
Insmed Inc
 Strong Buy 26 92% $143.40 -6.5%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -33.4%